The forkhead box O transcription factors convert a variety of external stimuli, including growth factors, nutrients, and oxidative stress, into diverse biological responses through modulation of specific gene expression. Forkhead box O regulation is principally achieved by two distinct mechanisms: post-translational modifications and protein-protein interactions. Among several modifications of forkhead box O factors, we focus on reversible acetylation, describing past research and current advances. In the latter part of this review, we also provide an overview of forkhead box O-binding partners that control the transcriptional activity of forkhead box O factors. These two layers of regulation mostly overlap and thereby enable a more precise finetuning of forkhead box O functions involved in metabolism, longevity, and tumor suppression. This article is part of a Special Issue entitled: PI3K-AKT-FoxO axis in cancer and aging.
Introduction
The forkhead box O (FoxO) transcription factors belong to the class O of the forkhead family that is characterized by an evolutionally conserved DNA-binding domain termed the "forkhead box." The FoxO proteins are the most divergent subfamily of Forkhead proteins, based on homologies within the DNA-binding domain. Invertebrates have one FoxO gene, e.g. Drosophila dFOXO and Caenorhabditis elegans DAF-16, while mammals have the following four FoxO family members: FoxO1 (FKHR), FoxO3 (FKHRL1), FoxO4 (AFX), and FoxO6. FoxO transcription factors play an important role in tumor suppression, energy metabolism, and lifespan extension by up-regulating target genes involved in cell cycle arrest, apoptosis, energy metabolism, and oxidative stress resistance [1, 2] .
FoxO transcription factors are regulated by a wide range of external stimuli, including insulin, insulin-like growth factor I (IGF-I), nutrients, cytokines, and oxidative stress. These environmental stimuli control FoxO activity by altering an intricate combination of post-translational modifications of FoxO, such as phosphorylation, acetylation, ubiquitination, and methylation, which in turn regulate subcellular localization, protein levels, DNA-binding properties, and transcriptional activity [3] . It has also been established that physical interactions between FoxO proteins and their various binding partners have significant consequences on transcriptional activity and other FoxO functions [4] . In this review, we discuss the regulatory mechanisms of FoxO transcription factors, focusing primarily on how FoxO acetylation and FoxO-binding partners control FoxO functions.
Reversible regulation of FoxO factors through acetylation/deacetylation

Acetylation occurs in FoxO proteins as well as other transcription factors
The initial catalyst that prompted us to investigate possible acetylation of FoxO transcription factors was the result of a yeast twohybrid screen. Using cAMP response element-binding protein (CREB)-binding protein (CBP) as bait, we identified the FoxO1 gene as a novel interaction partner of CBP [5] . CBP and its related protein p300 (CBP/ p300) are known histone acetyltransferases that act as coactivators of numerous transcription factors [6] . In fact, we found that CBP augments the transactivation function of FoxO1 [5] . On the other hand, accumulating evidence has shown that CBP/p300 can acetylate not only nucleosomal histones but also transcription factors such as p53 and GATA-1 [7, 8] . We therefore assessed whether FoxO proteins could be substrates for CBP and demonstrated that CBP acetylates FoxO1 at Lys-242, Lys-245, and Lys-262 (in mice) [5] . Since, in most cases, acetylation of transcription factors results in an increase in their transactivation functions, principally by enhancing DNA-binding ability [9] , acetylation of FoxO1, as well as of p53 and GATA-1, was also predicted to be an "active" modification. However, unlike with other factors, FoxO1 acetylation attenuates its transcriptional activity [5] . After extensive analysis, we proposed a model by which formation of the CBPFoxO1 complex causes histone acetylation and the recruitment of a preinitiation complex containing RNA polymerase II to the target promoter; the induced transcription can be attenuated by the subsequent FoxO1 acetylation by CBP [5] (Fig. 1) . Notably, this "hit and away" model can be applied to the regulation of FoxO4 [10] . However, the mechanism underlying the negative effect of acetylation on FoxO function remained to be elucidated.
Deacetylation of FoxO: a hint from genetic studies of C. elegans
Silent information regulator 2 (Sir2) belongs to the sirtuin family of NAD-dependent deacetylases, which respond to metabolic changes in the cellular environment, including the availability of nutrients/energy, and stress stimuli [11] . A series of genetic studies have shown that overexpression of Sir2 extends the lifespan of budding yeast and the nematode worm C. elegans [12] [13] [14] . In C. elegans, the extension of lifespan by Sir2 is entirely dependent on the presence of daf-16 [14] , which is the only C. elegans ortholog of the FoxO family of forkhead transcription factors. Given that acetylation serves as an inhibitory modification on the transcriptional activity of FoxO factors, this genetic correlation between Sir2 and daf-16 led us to hypothesize that the human Sir2 ortholog SIRT1 directly binds to and deacetylates FoxO proteins, and thereby restoring their transactivation function. We demonstrated that overexpression of SIRT1 in mammalian cells efficiently decreases the acetylation levels of FoxO1, which is in accordance with our hypothesis [5] . In addition, SIRT1 functions as a transcriptional coactivator of FoxO1 in an enzymatic activity-dependent manner [5] . When we reported this finding, several other groups also reported reversible acetylation of FoxO factors.
Reversible acetylation of FoxO factors: an intricate regulation mechanism
In 2004, three articles demonstrating a link between SIRT1 and FoxO factors were published [15] [16] [17] . Two common features of these studies were (1) increased FoxO acetylation by CBP/p300 under oxidative stress and (2) SIRT1-mediated deacetylation of FoxO. On the other hand, an important difference among these reports was the functional consequences of FoxO acetylation. Although it is still a matter of debate, below we briefly summarize the opposing effect of acetylation on FoxO function.
Positive effect of acetylation on FoxO transactivation function
Motta et al. first demonstrated that SIRT1 deacetylates and represses the activity of FoxO factors including FoxO1, FoxO3a, and FoxO4 [15] . Luciferase reporter assays showed that p300 enhances the transcriptional activity of FoxO3a, while SIRT1 contracts the p300-mediated transactivation of FoxO3a [15] . Furthermore, SIRT1 KO mice exhibited an increase in transcription of the FoxO target genes, IGFBP-1 and phosphoenolpyruvate carboxykinase (PEPCK) [15] . Although this regulation appears to be opposite to the genetic interaction of Sir2 with daf-16 in C. elegans, several studies have supported these results. Yang PP2A has been shown to be a FoxO1 phosphatase [76] . In the nucleus, FoxO recognizes and binds to the target gene promoter. CBP/p300 is recruited to the DNA-bound FoxO and stimulates the transcription by acetylating nucleosomal histones, whereas subsequent CBP/p300-mediated acetylation of FoxO impairs its DNA-binding. Accordingly, Akt could efficiently phosphorylate acetylated-FoxO and then phosphorylated FoxO interacts with 14-3-3 proteins in the nucleus, which in turn results in cytoplasmic retention of FoxO. Meanwhile, FoxO factors could be also deacetylated by SIRT2 and SIRT3 in the cytoplasm and in mitochondria, respectively. et al. reported that SIRT2, a cytoplasmic sirtuin, functions as FoxO1 deacetylase in prostate cancer cells [18] . They showed that binding of four and a half LIM2 (FHL2) to FoxO1 inhibited the transcriptional activity of FoxO1 by facilitating its deacetylation through SIRT1 [18] . In addition, Perrot and Rechler argued that acetylation of FoxO1 by p300 is responsible for its increased transactivation potency but is paradoxically enhanced by insulin stimulation [19] . However, a potential pitfall in evaluating the positive effects of acetylation on transcription is that often the distinction between FoxO acetylation and histone acetylation is not made. To resolve this issue, mutation analysis of the acetylated lysine residues would be useful to determine whether SIRT influences FoxO deacetylation or histone deacetylation.
Negative effect of acetylation on FoxO transactivation function
van der Horst et al. also reported that FoxO factors are subject to regulation by reversible acetylation [17] . However, unlike the consequences described above, they showed that CBP-mediated acetylation inhibited the transcriptional activity of FoxO4 [17] . Oxidative stress induced binding of CBP and acetylation of FoxO4, resulting in an association with SIRT1, which in turn deacetylated FoxO4, thereby prolonging its transactivation function [17] . Recently, they further demonstrated that reactive oxygen species (ROS) induce the formation of cysteine-thiol disulfide-dependent complexes of FoxO4 and CBP/p300, and that modulation of FoxO4 function by CBP/ p300-mediated acetylation is entirely dependent on the formation of this redox-dependent complex [20] . The authors concluded that acetylation acts as a negative control pathway for FoxO factors; these findings directly link cellular redox status to the activity of the longevity gene FoxO [20] .
Dual effects of acetylation on FoxO transactivation function
In contrast, Brunet et al. reported that SIRT1 has a dual effect on FoxO3a function, that is, SIRT1 enhances the ability of FoxO3a to confer cell cycle arrest and resistance to oxidative stress but also inhibits the ability of FoxO3a to induce cell death [16] . Using an inducible FoxO3 consisting of a fusion between constitutively active FoxO3a and the ligand-binding domain of the estrogen receptor, SIRT1 increased expression of FoxO targets p27 and GADD45 but appeared to diminish expression of pro-apoptotic BIM [16] . In addition, we and others demonstrated that SIRT1 stimulates expression of MnSOD, IGFBP-1, and GADD45 [5, 21, 22] . Taken together, these findings suggest that gene-specific contexts could determine the effects of FoxO acetylation/ deacetylation on FoxO-induced gene expression. On the other hand, given that SIRT1 also deacetylates other transcription factors (e.g. p53) [23] , it is possible that SIRT1-mediated cell survival may not be attributed to only FoxO deacetylation.
How does FoxO acetylation impact its transactivation function?
One of the most intriguing questions is how acetylation of FoxO proteins influences their transactivation function. To date, there has been no report on the mechanisms underlying acetylation-dependent activation of FoxO proteins, while accumulating evidence has revealed how acetylated FoxO proteins decrease their transactivation function.
FoxO acetylation inhibits DNA-binding activity
In general, acetylation of transcription factors alters their activity, but this is dependent on the functional domains that are acetylated [9] . In the case of FoxO1, three acetylation sites are located within the wing 2 (W2) region of the forkhead domain. Because the C-terminus of the forkhead domain, which includes the W2 region, directly participates in DNA recognition and/or stabilization of the FoxO-DNA complex [24] , acetylation of positively charged lysine residues in W2 might inhibit FoxO binding to the DNA.
In fact, gel shift assays using acetylation-defective (Lys to Arg) and acetylation-mimicking (Lys to Ala, Lys to Gln) mutants suggested that acetylation of FoxO1 attenuates DNA-binding activity [25] . Consistent with these findings, analysis of the 2.7 Å crystal structure of the FoxO3a DNA-binding domain bound to DNA revealed that Lys-245 directly interacts with the phosphate group of DNA, and the substitution of both Lys-242 and Lys-245 with alanine residues reduced the DNA-binding affinity of FoxO3a [26] . Brent et al. demonstrated that the flexible W2 region of the forkhead domain is not observed in the structure but is necessary for DNA-binding, and p300-mediated acetylation of FoxO1 reduces DNA-binding affinity [27] . These studies provide a structural basis for understanding the correlation between FoxO1 acetylation and its inhibitory effect on DNA binding [28] .
In addition to SIRT1, other sirtuins such as SIRT2 and SIRT3 are involved in the regulation of FoxO3 activity by modulating DNA binding through reversible acetylation (Fig. 1) . Wang et al. reported that the expression of SIRT2 is elevated under oxidative stress and consequently increases SIRT2-mediated deacetylation of FoxO3a [29] . By chromatin-immunoprecipitation (ChIP) assay, they showed an association between increase in binding of FoxO3a to the p27 promoter region and overexpression of SIRT2 [29] . Similarly, SIRT3, a mitochondrial sirtuin, has been shown to form a physical interaction with FoxO3a in mitochondria [30] . Overexpression of wild type, but not enzymatically inactive, SIRT3 enhanced FoxO3a DNA-binding to the MnSOD promoter as well as FoxO3a-dependent gene expression [30] . Collectively, these results support a model in which acetylated FoxO has a lower affinity for DNA than the non-acetylated form.
Besides its key role as a DNA-binding transcription factor, FoxO1 has also been shown to stably bind to target sites on nucleosomes, and to act as a "chromatin remodelers" by perturbing histone-DNA contacts in a chromatin context [31] . Hatta et al. investigated the effects of FoxO1 acetylation on chromatin properties and demonstrated that acetylation significantly reduces the affinity of FoxO1 for its binding sites in nucleosomal DNA, but acetylation does not alter stable nucleosome binding and remodeling functions [32] .
FoxO acetylation promotes Akt-mediated phosphorylation of FoxO
In addition to an inhibitory effect on DNA binding, we have shown that FoxO1 acetylation causes an increase in Akt-mediated phosphorylation of FoxO1 at Ser-253, leading to the following translocation from the nucleus to the cytoplasm [25] . Given that FoxO1 DNAbinding is rapid and reversible and that this unstable state could provide an opportunity for Akt-mediated phosphorylation at Ser-253, we proposed a model in which acetylation at the W2 region is the initial step facilitating the dissociation of FoxO1 from DNA; consequently, Akt readily phosphorylates FoxO1 at Ser-253, thereby further reducing the binding of FoxO1 to DNA (Fig. 1) [25] . This model is supported by a study on FoxO1 translocation using living cell imaging, which showed that SIRT1 activation or hydrogen peroxide treatment (which enhances FoxO1-SIRT1 interaction) overrides the phosphorylation-dependent nuclear exclusion of FoxO1, even when Aktsignaling is activated in cells [33] .
This interplay between acetylation and phosphorylation in FoxO regulation was also found in adipocyte differentiation. Jing et al. demonstrated that reducing SIRT2 expression accompanied with adipogenesis increases acetylation of FoxO1, thereby facilitating Aktmediated phosphorylation and subsequent cytoplasmic translocation of FoxO1 [34] . Because nuclear FoxO1 binds to and suppresses the transcription factor PPARγ, a master regulator of adipogenesis [35] , reversible acetylation of FoxO1 plays a critical role in adipocyte differentiation. Furthermore, Wang and Tong demonstrated that SIRT2-mediated deacetylation of FoxO1 represses adipogenesis by increasing the binding affinity of FoxO1 for PPARγ [36] . On the other hand, SIRT3 has been shown to block the cardiac hypertrophic response by augmenting FoxO3a-dependent transcription [37] . Although changes in FoxO3a phosphorylation were not observed, increased SIRT3 levels under oxidative stress resulted in FoxO3a deacetylation, thereby increasing the nuclear localization and transcriptional activity of FoxO3a [37] .
FoxO acetylation inhibits ubiquitination
While FoxO proteins are relatively stable, they can still be degraded via an ubiquitination-proteasome pathway in response to insulin and serum growth factors [38, 39] . Given that ubiquitination and acetylation occur on lysine residues, FoxO acetylation could be inversely correlated with ubiquitination by competing for the same lysine residues. Using acetylation-defective and acetylation-mimicking mutants, Kitamura et al. found that these mutual effects play an important role in the FoxO1-dependent oxidative damage response in pancreatic β cells [40] . Under oxidative stress, FoxO1 acetylation prevented ubiquitin-dependent degradation and then induced a complex formation with promyelocytic leukemia protein (PML) and SIRT1 [40] . This interaction targeted FoxO1 to PML nuclear bodies, thereby activating expression of NeuroD and MafA, Insulin2 gene transcription factors [40] . The authors proposed a model in which FoxO1 acetylation confers protection against ubiquitination and retains FoxO1 in the nucleus together with PML and SIRT1, while deacetylation of FoxO1 by SIRT1 promotes FoxO1-dependent transcription and accelerates FoxO1 degradation [40] .
Effects of FoxO acetylation on autophagy
FoxO1 acetylation is also involved in cytosolic FoxO1 function independent of its transcriptional activity. Zhao et al. reported that endogenous FoxO1 is required for autophagy, a regulated bulk degradation process in which cytoplasmic constituents such as damaged proteins and organelles are delivered to the lysosome for digestion [41] . In response to oxidative stress or serum starvation, FoxO1 was acetylated by dissociation from SIRT2, and the acetylated FoxO1 interacted with an E1-like protein autophagy-related 7 (Atg7) [41] . The authors showed that this interaction could suppress tumor growth by triggering autophagy and ultimately cell death in a transcription-independent manner [41] . Thus, FoxO acetylation finetunes not only the transactivation function but also the autophagic process by modulating protein-protein interactions.
Regulation of FoxO factors by protein-protein interactions
In addition to various posttranslational modifications, FoxO transcription factors are regulated by a variety of intracellular proteins through direct protein-protein interactions [4] . In this section, we briefly summarize FoxO-binding partners till date, particularly those whose interactions affect the transactivation function of FoxO factors.
Regulation of FoxO by nuclear receptors
The nuclear receptor superfamily is a structurally related, diverse array of transcriptional factors characterized by a central DNAbinding domain and a C-terminal ligand-binding domain. They mediate the signals of a broad variety of fat-soluble hormones, including the steroid and vitamin D3 hormones, thyroid hormones, and vitamin A-derived hormones and analogs, thereby leading to the expression of target genes involved in reproduction, development, proliferation, and metabolism [42] . Although FoxO factors have been shown to associate with various nuclear receptors (NRs) and these interactions often affect the transcriptional activities of both parties, we will focus on NR-mediated regulation of FoxO function.
PPARα and PPARγ
The peroxisome proliferators-activated receptor (PPAR) family is composed of PPARα β/δ, and γ. PPARα is expressed in the liver, heart, muscle, and kidney, while PPARγ is highly enriched in adipocytes and macrophages. PPAR forms a heterodimer with retinoid X receptor (RXR), and activates target genes involved in nutrient sensing and regulation of carbohydrate and lipid metabolism. PPARγ functions as a master regulator of adipocyte differentiation, while FoxO1 activity in preadipocytes has been shown to inhibit differentiation [43] . The interaction between FoxO1 and PPARγ was identified by a yeast twohybrid screen using PPARγ as bait [35] . Overexpression of PPARγ/RXR repressed FoxO1-dependent transcription, and this inhibitory effect was further augmented by treatment with the PPARγ agonist rosiglitazone [35] . Importantly, FoxO1 also antagonized PPARγ activity, indicating that these transcription factors functionally interact in a reciprocal antagonistic manner [35] . Thus, FoxO1-mediated inhibition of adipocyte differentiation could account for the direct binding and opposing action of PPARγ and FoxO1.
On the other hand, PPARα has been shown to regulate the hypolipidemic action of fibrates by antagonizing FoxO1 activity [44] . PPARα physically binds to and counteracts FoxO1 in hepatic apolipoprotein C-III (ApoC-III) expression [44] . A ChIP assay demonstrated that PPARα interferes with FoxO1 binding to the apoC-III promoter in HepG2 cells [44] . Given the structural similarity of PPAR family members, inhibition of FoxO1 DNA-binding may be a mechanism for PPARγ-mediated FoxO1 repression.
Androgen receptor
Androgen receptor (AR) is a ligand-dependent transcription factor activated by testosterone or 5α-dihydrotestosterone. Dysregulation of AR is often implicated in prostate cancer progression [45] . Li et al. demonstrated that AR represses FoxO1 in a ligand-dependent and Akt-independent manner [46] . This repression was achieved by protein-protein interactions between AR and FoxO1, which in turn inhibited DNA-binding activity of FoxO1 [46] . Accordingly, AR repressed FoxO1-mediated expression of the Fas ligand, thereby impairing prostate cancer cell apoptosis and cell cycle arrest [46] . This study revealed a novel mechanism for androgen-mediated prostate cancer cell survival that appears to be independent of the activity of AR-mediated transcription.
Estrogen receptor
Estrogen receptor (ER) transduces estrogen signals and subsequently activates the expression of genes that stimulate cell proliferation, invasion, metastasis, and angiogenesis in mammary gland tissue, ovarian tissue, and the uterus [47] . Schuur et al. reported that ERα interacts with FoxO1 in a ligand-dependent manner and reciprocally represses FoxO1-mediated transcription [48] . In MCF-7 cells, FoxO1-induced cell cycle arrest was blocked by treatment with estradiol [48] . Furthermore, overexpression of FoxO1 in estrogendependent human breast cancer cells inhibited proliferation, suggesting the physiological significance of the ER-FoxO1 interaction in the development and maintenance of cancer cells.
Regulation of FoxO by DNA repair proteins
One of the most intriguing functions of FoxO transcription factors is their conserved ability to extend lifespan [49] . Interestingly, recent studies using a tandem affinity purification method have shown that several DNA damage response proteins are novel FoxO-binding partners. Given that accumulation of DNA damage is considered to be an underlying cause of aging [50] , a direct link between FoxO proteins and the DNA repair pathway suggests a novel regulatory mechanism of FoxO in response to DNA damage.
Ku70/Ku80
Ku is a heterodimeric protein consisting of two subunits, Ku70 and Ku80, and plays a crucial role in DNA double-strand break repair, especially in non-homologous end joining [51] . Recently, Brenkman et al. identified the heterodimer Ku70/Ku80 as a novel protein complex regulating FoxO4 activity [52] . Ku70 was required for ternary complex formation; moreover, the direct interaction between FoxO4 and Ku70 inhibited FoxO4-mediated p27 kip1 transcription and G1 cell cycle arrest [52] . This interaction was sensitive to oxidative stress but stoichiometry followed a non-linear doseresponse curve, that is, low levels of oxidative stress increased interactions, peaking at 50 μM of hydrogen peroxide, after which dissociation occurred [52] . These results imply that Ku70 plays a key role in the regulation of a cellular adaptive stress response through coordinated inhibition of FoxO4-mediated p27 kip1 expression [52] .
Interestingly, since a genetic study has demonstrated that a C. elegans ortholog of Ku70 interacts with insulin-like signaling to modulate lifespan [53] , a conserved link between Ku70 and FoxO may contribute to lifespan regulation.
FANCD2
Fanconi anemia (FA) is a genomic instability syndrome characterized by autosomal recessive disorders such as bone marrow failure, developmental abnormalities, and increased incidence of cancers. FA is caused by mutations in at least 13 distinct genes, and all of the 13 FA genes products are thought to function in a common DNA damage response pathway cooperating with other DNA repair proteins [54] . Li et al. reported a novel oxidative stress response pathway controlled by a FA protein, Fanconi anemia complementation group D2 (FANCD2), and FoxO3a [55] . FoxO3a, but not FoxO1 and FoxO4, specifically associated with FANCD2 and colocalized with FANCD2 nuclear foci following treatment with hydrogen peroxide [55] . This FANCD2-FoxO3a interaction was entirely dependent on oxidative stress-induced FANCD2 monoubiquitination [55] . Importantly, coexpression of FANCD2 with FoxO3a resulted in transcriptional upregulation of FoxO-targeted antioxidative genes such as sod1, sod2, glutathione peroxidase 1, and catalase [55] . These results suggest that the FANCD2-FoxO3a complex confers cellular resistance to oxidative stress.
PARP-1
Poly(ADP-ribose)polymerase-1 (PARP-1) is an abundant and ubiquitous nuclear enzyme that catalyzes the NAD-dependent addition of ADP-ribose polymers to target proteins [56] . PARP-1 is involved in diverse aspects of cellular response to various forms of damage and is essential for the repair of single-strand DNA breaks via the base excision repair pathway [57] . We found that PARP-1 binds to and represses transcriptional activity of FoxO1 independently of its enzymatic activity [58] . PARP-1 inhibited FoxO1-mediated p27 kip1 expression by binding to its promoter region and knockdown of PARP-1 led to a decrease in cell proliferation in a FoxO1 function-dependent manner, suggesting that PARP-1 acts as a corepressor of FoxO1, and plays an important role in proper cell proliferation by regulating p27 kip1 expression [58] . Alternatively, although PARP-1 poly(ADPribosyl)ated FoxO1, the functional significance of poly(ADP-ribosyl) ation of FoxO1 remains unknown [58] .
Regulation of FoxO by other mediators
PGC-1α
PPARγ coactivator 1 (PGC-1α) plays a key role in the regulation of mitochondrial biogenesis, thermogenesis, and gluconeogenesis through coactivation of several different transcription factors [59] . Puigserver et al. showed that PGC-1α interacted with and coactivated FoxO1 in hepatocytes, but this interaction was disrupted by Aktmediated phosphorylation of FoxO1 in response to insulin [60] . Furthermore, the PGC-1α-induced up-regulation of glucose-6-phosphatase (G6Pase) and PEPCK was diminished by a dominant negative form of FoxO1 in cells and in mice, indicating that activation of these gluconeogenic genes by PGC-1α requires FoxO1 function [60] . However, a recent study suggested that the synergy between PGC-1α and FoxO1 is not the consequence of their direct interaction [61] . Using G6Pase promoter-luciferase constructs carrying mutations in FoxO1 and hepatocyte nuclear factor 4α (HNF4α) binding sites, the authors demonstrated that binding sites of HNF4α, but not FoxO1, are required for PGC-1α to affect the G6Pase promoter [61] . Thus, further studies are needed to clarify whether PGC-1α indeed functions as a direct coactivator of FoxO1 in the transcription of G6Pase.
In addition to its role in hepatic gluconeogenesis, the FoxO-PGC-1α interaction has been shown to be involved in oxidative stress protection in vascular endothelium. Olmos et al. reported that FoxO3a directly activates a set of genes related to ROS detoxification in vascular endothelial cells [62] . The FoxO3a-mediated gene expression required direct binding to PGC-1α and recruitment to the promoter regions. Because both FoxO1 and FoxO3a are direct transcriptional regulators of PGC-1α expression [63, 64] , a positive feedback loop appears to regulate the oxidative stress response in vascular endothelium.
β-catenin
β-catenin is a multifunctional protein that acts not only as a component of the cadherin-based cell adhesion system but also as a transcriptional coactivator of the Wnt/T-cell factor (TCF)-mediated transcription [65] . Essers et al. have shown an evolutionarily conserved interaction between β-catenin and FoxO in oxidative stress signaling [66] . β-catenin directly bound to FoxO factors and potentiated their transcriptional activity in response to hydrogen peroxide [66] . Notably, genetic analysis demonstrated that BAR-1, a C. elegans ortholog of β-catenin, is required for the function of DAF-16 in the regulation of dauer formation and lifespan [66] . BAR-1 plays an essential role in the oxidative stress-induced expression of the DAF-16 target gene sod-3 [66] . Moreover, Almeida et al. have reported that oxidative stress promotes the association of FoxOs with β-catenin, thereby enhancing their transcriptional activity, and this is inversely correlated with Wnt/TCF-mediated transcription and osteoblast differentiation [67] . These results suggest that the diversion of the limited pool of β-catenin from TCF to FoxO upon increased oxidative stress attenuates osteogenesis.
C/EBPα and C/EBPβ
CCAAT/enhancer-binding protein (C/EBP) is a family of basic region-leonine zipper transcription factors that are implicated in many aspects of biological processes, such as female fertility, gluconeogenesis, adipogenesis, and hematopoiesis [68] . The first cue for the interplay between FoxO and C/EBP is cAMP stimulation in endometrial stoma (ES) cells causing induction and nuclear localization of FoxO1 as well as upregulation of C/EBPβ expression. Decidualization of ES cells requires elevated intracellular cAMP levels and concomitant PKA activation [69] . During this process, expression of decidual prolactin (dPRL) in ES cells is observed; dPRL is widely used as a biochemical marker of the decidual transformation. Christian et al. demonstrated that the coexpression of C/EBPβ with FoxO1 synergistically activated dPRL promoter activity, whereas this effect was abolished when the FoxO1-binding site of C/EBPβ was mutated [70] . It has been assumed that C/EBPβ is recruited to the dPRL promoter through its interaction with FoxO1, which binds directly to a FoxO site in the promoter.
On the other hand, a link between C/EBPα and FoxO1 has been shown to play an essential role in gluconeogenesis during liver development. Sekine et al. demonstrated that expression of FoxO1 was markedly elevated in perinatal liver and augmented C/EBPα-dependent transcription [71] . FoxO1 directly interacted with C/EBPα and was recruited to the promoter of PEPCK in a C/EBPα-dependent manner [71] . These findings suggest that the FoxO1-C/EBPα complex cooperatively regulates gluconeogenesis and also links insulin signaling to C/EBPα during liver development.
Smad
Transforming growth factor-β (TGF-β) is a cytokine that elicits cytostatic signaling regulating proliferation, differentiation, migration, and cell death. Upon TGF-β stimulation, activated TGF-β type I receptor phosphorylates Smad2 and 3, both of which promote complex formation with Smad4, thereby leading to the activation of target genes in the nucleus [72] . Knowledge of the functional interplay between FoxO and Smad emerged from genetic evidence that DAF-2 signaling acts synergistically with the DAF-7-mediated signaling pathway; DAF-7 is the C. elegans ortholog of TGF-β [73] . In mammals, the interaction between FoxO and Smad contributes to the control of neuroepithelial and glioblastoma cell proliferation [74] . In response to TGF-β, FoxO binds to and activates the p21 cip1 promoter, and moreover, Smad3 and Smad4 form a complex with FoxO proteins on the p21 cip1 promoter in a TGF-β-dependent manner, thereby inducing FoxO-mediated p21 cip1 transcription [74] .
Alternatively, Seoane et al. have also identified FoxG1 as a negative regulator of the FoxO-Smad3/4 complex [74] . FoxG1 associated with FoxO and antagonized the TGF-β-induced upregulation of p21 cip1 [74] .
Furthermore, inhibition of PI3K signaling together with TGF-β stimulation consistently leads to an increase in p21 cip1 expression and impaired cell proliferation [74] . Knockdown of FoxG1 in this condition strengthens p21 cip1 induction and growth arrest in glioblastoma cells [74] . These findings suggest that FoxO factors integrate TGF-β-SMAD, PI3K, and FoxG1 signaling to regulate neuronal growth and oncogenesis.
Conclusion
In this review, although we focused on the regulation of FoxO transcription factors by acetylation and protein-protein interactions, various post-translational modifications and numerous binding protein partners also fine-tune the precise regulation of FoxO. This has led to the proposal that a specific pattern of FoxO posttranslational modifications is "read" by specific binding partners as if it were a "FoxO code" [3] .
Emerging evidence also indicates that FoxO factors have noncanonical functions independent of their roles as transcription factors. For example, FoxO3a directly interacts with ataxia telangiectasia mutated (ATM) to promote its autophosphorylation at Ser-1981, which is correlated with ATM activation, thereby potentiating its downstream mediators to form a DNA repair complex in response to DNA damage [75] . It is likely that the control of these noncanonical functions of FoxO factors is also achieved by a FoxO code that could determine when and where interactions should occur. As described in this review, oxidative stress or serum starvation induces FoxO1 acetylation, and then acetylated FoxO1 binds to Atg7 to trigger autophagy [41] . FoxO modifications such as poly (ADP-ribosyl)ation, which have no effect on transcriptional activity [58] , may thus be involved in the regulation of non-canonical functions of FoxO transcription factors. Further studies based on post-translational modifications and protein-protein interactions will provide new insight into how FoxO factors translate a variety of environmental stimuli into specific gene expressions and other cellular functions to prevent aging and age-dependent diseases, including cancer and diabetes.
